Infant Bacterial Therapeutics AB products

IBP-9414 for the prevention of necrotizing enterocolitis (NEC) contains the active substance Lactobacillus reuteri, which is a co-evolved human bacterial strain naturally present in breast milk. Lactobacillus reuteri is a live bacteria known to be anti-inflammatory, anti-pathogenic and beneficial to gut motility.

Gastroschisis is a rare, life-threatening and debilitating birth abnormality in late preterm infants where the infant is born with externalized intestines.